Leo has certainly done his part in returning value
Post# of 72440
What Cellceutix looked like when Leo Ehrlich took over:
At 06/30/2010 there were 92M shares outstanding.
At 06/30/2010 the company had a cash balance of 3,994 dollars
At 06/30/2010 the company had assets of 102K
At 06/30/2010 the stock holders had a deficit of 4.8M
At 06/30/2010 the share price closed at .54 cents
At 06/30/2010 the company had no clinical trials
Looks pretty damned good to me.
GO CTIX